Area of research
Hepatology · Surgery
Research interest
Research interests include Organ Transplantation Techniques and Outcomes, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, and Hepatocellular Carcinoma Treatment and Prognosis.
Bloodstream infection subtypes and characteristics comparing solid organ transplant and nontransplant populations
Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation.
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma
The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in 2 specialized centers.
Cefepime-zidebactam therapy for extensively drug-resistant <i>Pseudomonas aeruginosa</i> and <i>Klebsiella pneumoniae</i> infection as a bridge to liver transplantation
Living donor liver re-transplantation: a viable option?
Tumor-informed circulating tumor DNA assay for surveillance post-liver transplantation in patients with hepatocellular and cholangiocarcinoma.
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study
The learning curve for robotic living donor right hepatectomy: Analysis of outcomes in 2 specialized centers
Proceedings of the 28th Annual Congress of the International Liver Transplantation Society.
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21)
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant
Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis
Novel Benchmark Values for Redo Liver Transplantation
mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
Are short-term complications associated with poor allograft and patient survival after liver transplantation? A systematic review of the literature and expert panel recommendations.
An imageomics and multi-network based deep learning model for risk assessment of liver transplantation for hepatocellular cancer
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis
Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV‐Viremic Donors
The Rise of the Machines: Will They Fulfill the Restoration Promise?